Sponsored by:

ACC/AHA Release Recommendations For Congenital and Genetic Heart Disease Screenings in Youth: Click Here to Learn More Full CardioSource Coverage of TCT 2014 PRIMA: PFO Closure in Patients With Refractory Migraine With Aura SECURITY: Six Months vs. 12 Months of DAT Following DES Implantation ISAR-TRIPLE: Six Weeks vs. Six Months Clopidogrel in DES Patients Receiving Triple Therapy ABSORB II: Everolimus-Eluting Bioresorbable Scaffold vs. Everolimus-Eluting Metallic Stent in CAD

Featured Videos

Advertisement
Advertisement